skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Methods and kits for predicting a response to an erythropoietic agent

Abstract

Methods for predicting a response to an erythropoietic agent in a subject include providing a biological sample from the subject, and determining an amount in the sample of at least one peptide selected from the group consisting of SEQ ID NOS: 1-17. If there is a measurable difference in the amount of the at least one peptide in the sample, when compared to a control level of the same peptide, the subject is then predicted to have a good response or a poor response to the erythropoietic agent. Kits for predicting a response to an erythropoietic agent are further provided and include one or more antibodies, or fragments thereof, that specifically recognize a peptide of SEQ ID NOS: 1-17.

Inventors:
; ; ;
Issue Date:
Research Org.:
University of Louisville Research Foundation, Inc., Louisville, KY (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1184560
Patent Number(s):
9057731
Application Number:
13/167,478
Assignee:
University of Louisville Research Foundation, Inc. (Louisville, KY)
Patent Classifications (CPCs):
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
DOE Contract Number:  
FG02-05ER64060
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Merchant, Michael L., Klein, Jon B., Brier, Michael E., and Gaweda, Adam E. Methods and kits for predicting a response to an erythropoietic agent. United States: N. p., 2015. Web.
Merchant, Michael L., Klein, Jon B., Brier, Michael E., & Gaweda, Adam E. Methods and kits for predicting a response to an erythropoietic agent. United States.
Merchant, Michael L., Klein, Jon B., Brier, Michael E., and Gaweda, Adam E. Tue . "Methods and kits for predicting a response to an erythropoietic agent". United States. https://www.osti.gov/servlets/purl/1184560.
@article{osti_1184560,
title = {Methods and kits for predicting a response to an erythropoietic agent},
author = {Merchant, Michael L. and Klein, Jon B. and Brier, Michael E. and Gaweda, Adam E.},
abstractNote = {Methods for predicting a response to an erythropoietic agent in a subject include providing a biological sample from the subject, and determining an amount in the sample of at least one peptide selected from the group consisting of SEQ ID NOS: 1-17. If there is a measurable difference in the amount of the at least one peptide in the sample, when compared to a control level of the same peptide, the subject is then predicted to have a good response or a poor response to the erythropoietic agent. Kits for predicting a response to an erythropoietic agent are further provided and include one or more antibodies, or fragments thereof, that specifically recognize a peptide of SEQ ID NOS: 1-17.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2015},
month = {6}
}

Patent:

Save / Share:

Works referenced in this record:

Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option
journal, December 2006


Anemia of inflammation: the cytokine-hepcidin link
journal, May 2004


Specificity of interactions of galectin-3 with Chrp, a cysteine- and histidine-rich cytoplasmic protein
journal, February 2003


Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor α, and Oncostatin M Receptor β by Distinct Mechanisms
journal, October 2001


Inflammatory Markers and Platelet Aggregation Tests as Predictors of Hemoglobin and Endogenous Erythropoietin Levels in Hemodialysis Patients
journal, January 2002


Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas
journal, July 2008


Model Predictive Control of Erythropoietin Administration in the Anemia of ESRD
journal, January 2008


Role of cytokines in the response to erythropoietin in hemodialysis patients
journal, October 1998


Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease
journal, February 2010


Precision proteomics: The case for high resolution and high mass accuracy
journal, September 2008


Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)
journal, June 2003


Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis
journal, March 2006


Interaction of a novel cysteine and histidine-rich cytoplasmic protein with galectin-3 in a carbohydrate-independent manner
journal, March 2000


Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria
journal, July 2009


Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation
journal, October 2008


Dual Oncostatin M (OSM) Receptors: Cloning And Characterization Of An Alternative Signaling Subunit Conferring OSM-Specific Receptor Activation
journal, December 1996


IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
journal, May 2004


Targeted disruption of oncostatin M receptor results in altered hematopoiesis
journal, November 2003


Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
journal, January 2008


Hypoxia-inducible factor 1α is up-regulated by oncostatin M and participates in oncostatin M signaling
journal, March 2009


Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
journal, September 2008


Epoetin requirements predict mortality in hemodialysis patients
journal, November 2004